WHO ICTRP trial
Exploratory Pilot Study of Monoclonal Antibody (SIF001) for the Treatment of…
ChiCTR2400089740 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400089740 |
|---|---|
| Public title | Exploratory Pilot Study of Monoclonal Antibody (SIF001) for the Treatment of Drug-Resistant Epilepsy |
| Scientific title | Exploratory Pilot Study of Monoclonal Antibody (SIF001) for the Treatment of Drug-Resistant Epilepsy |
| Primary sponsor | Xuanwu Hospital, Capital Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | Drug-Resistant Epilepsy |
| Interventions | Treatment Group:Monoclonal Antibody (SIF001) |
| Registration date | Sep 14, 2024 |
| Target size | Treatment Group:6 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: